Company intelligence
CORXEL Pharmaceuticals
Our mission is to develop innovative cardiometabolic therapies globally.
Biotechnology Research
Berkeley Heights, US
64 employees
Founded 2019
1 public signals
About CORXEL Pharmaceuticals
CORXEL is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic conditions around the world. Led by an experienced management team that has a strong track record of identifying, in-licensing and developing attractive clinical product candidates directed at validated targets with proven mechanisms of action (MoAs), CORXEL's diverse portfolio of clinical-stage product candidates has the potential to redefine treatment standards and address key limitations of current therapies for multiple cardiometabolic indications.
Verified activity
Signals from CORXEL Pharmaceuticals
1 published signal